Your browser doesn't support javascript.
loading
High-risk Pancreatic Anastomosis Versus Total Pancreatectomy After Pancreatoduodenectomy: Postoperative Outcomes and Quality of Life Analysis.
Marchegiani, Giovanni; Perri, Giampaolo; Burelli, Anna; Zoccatelli, Fabio; Andrianello, Stefano; Luchini, Claudio; Donadello, Katia; Bassi, Claudio; Salvia, Roberto.
  • Marchegiani G; Department of General and Pancreatic Surgery, Verona University Hospital, Verona, Italy.
  • Perri G; Department of General and Pancreatic Surgery, Verona University Hospital, Verona, Italy.
  • Burelli A; Department of General and Pancreatic Surgery, Verona University Hospital, Verona, Italy.
  • Zoccatelli F; Department of General and Pancreatic Surgery, Verona University Hospital, Verona, Italy.
  • Andrianello S; Department of General and Pancreatic Surgery, Verona University Hospital, Verona, Italy.
  • Luchini C; Department of Pathology, Verona University Hospital, Verona, Italy.
  • Donadello K; Department of Anesthesia and Intensive Care, Verona University Hospital, Verona, Italy.
  • Bassi C; Department of General and Pancreatic Surgery, Verona University Hospital, Verona, Italy.
  • Salvia R; Department of General and Pancreatic Surgery, Verona University Hospital, Verona, Italy.
Ann Surg ; 276(6): e905-e913, 2022 12 01.
Article en En | MEDLINE | ID: mdl-33914471
ABSTRACT

OBJECTIVE:

To evaluate TP as an alternative to PD in patients at high-risk for popf.

BACKGROUND:

Outcomes of high-risk PD (HR-PD) and TP have never been compared.

METHODS:

All patients who underwent PD or TP between July 2017 and December 2019 were identified. HR-PD was defined according to the alternative fistula risk score. Postoperative outcomes (primary endpoint), pancreatic insufficiency, and quality of life after 12 months of follow-up (QoL) were compared between HR-PD or planned PD intraoperatively converted to TP (C-TP).

RESULTS:

A total of 566 patients underwent PD and 136 underwent TP during the study period. One hundred one (18%) PD patients underwent HR-PD, whereas 86 (63%) TP patients underwent C-TP. Postoperatively, the patients in the C-TP group exhibited lower rates of postpancreatectomy hemorrhage (15% vs 28%), delayed gastric emptying (16% vs 34%), sepsis (10% vs 31%), and Clavien-Dindo ≥3 morbidity (19% vs 31%) and had shorter median lengths of hospital stay (10 vs 21 days) (all P < 0.05). The rate of POPF in the HR-PD group was 39%. Mortality was comparable between the 2 groups (3% vs 4%). Although general, cancer- and pancreas-specific QoL were comparable between the HR-PD and C-TP groups, endocrine and exocrine insufficiency occurred in all the C-TP patients, compared to only 13% and 63% of the HR-PD patients, respectively, and C-TP patients had worse diabetesspecific QoL.

CONCLUSIONS:

C-TP may be considered rather than HR-PD only in few selected cases and after adequate counseling.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pancreatectomía / Neoplasias Pancreáticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pancreatectomía / Neoplasias Pancreáticas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article